Literature DB >> 15962720

Obesity as a risk factor for premenstrual syndrome.

Saba Woldemichael Masho1, Tilahun Adera, Jeannette South-Paul.   

Abstract

PURPOSE: To determine the association between obesity and Premenstrual Syndrome (PMS).
METHODS: A cross-sectional study was conducted using a random-digit dialing method. The sampling frame consisted of all possible area codes, exchanges, and 4-digit suffixes in Virginia. A total of 874 women between the ages of 18-44 residing in the state of Virginia between August 1 and September 15, 1994 were interviewed. Cases were defined as women who reported severe or extreme PMS symptom changes using the Shortened Premenstrual Assessment Form. The main exposure variable was obesity as measured by Body Mass Index.
RESULTS: The prevalence of PMS in Virginia was 10.3 percent. Obese women (BMI > or = 30) had nearly a three-fold increased risk for PMS than non-obese women OR = 2.8 (95% CI = 1.1, 7.2). PMS was more prevalent among whites, younger women, and smokers.
CONCLUSION: This data provided evidence that obesity is strongly associated with PMS. Since obesity is a modifiable risk factor, PMS management strategies should not only consider factors such as, high stress, and smoking but also obesity.

Entities:  

Mesh:

Year:  2005        PMID: 15962720     DOI: 10.1080/01443610400023049

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  24 in total

1.  Increased childhood abuse in patients with premenstrual dysphoric disorder in a Turkish sample: a cross-sectional study.

Authors:  Esra Akyol Soydas; Yakup Albayrak; Basak Sahin
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-24

2.  Adiposity and the development of premenstrual syndrome.

Authors:  Elizabeth R Bertone-Johnson; Susan E Hankinson; Walter C Willett; Susan R Johnson; JoAnn E Manson
Journal:  J Womens Health (Larchmt)       Date:  2010-09-27       Impact factor: 2.681

3.  Dietary B vitamin intake and incident premenstrual syndrome.

Authors:  Patricia O Chocano-Bedoya; JoAnn E Manson; Susan E Hankinson; Walter C Willett; Susan R Johnson; Lisa Chasan-Taber; Alayne G Ronnenberg; Carol Bigelow; Elizabeth R Bertone-Johnson
Journal:  Am J Clin Nutr       Date:  2011-02-23       Impact factor: 7.045

4.  Health advantage for black women: patterns in pre-menstrual dysphoric disorder.

Authors:  C E Pilver; S Kasl; R Desai; B R Levy
Journal:  Psychol Med       Date:  2010-11-26       Impact factor: 7.723

Review 5.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

6.  Cigarette smoking and the development of premenstrual syndrome.

Authors:  Elizabeth R Bertone-Johnson; Susan E Hankinson; Susan R Johnson; Joann E Manson
Journal:  Am J Epidemiol       Date:  2008-08-13       Impact factor: 4.897

Review 7.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

8.  Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder.

Authors:  Elizabeth R Bertone-Johnson; Susan E Hankinson; Susan R Johnson; JoAnn E Manson
Journal:  J Womens Health (Larchmt)       Date:  2009-12       Impact factor: 2.681

9.  Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study.

Authors:  Elizabeth R Bertone-Johnson; Brian W Whitcomb; Janet W Rich-Edwards; Susan E Hankinson; JoAnn E Manson
Journal:  Am J Epidemiol       Date:  2015-11-24       Impact factor: 4.897

10.  Premenstrual syndrome.

Authors:  Kimberly Ann Yonkers; P M Shaughn O'Brien; Elias Eriksson
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.